Professor | Honglin Yan | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Honglin Yan
Contact Information	honglin@whu.edu.cn
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Honglin Yan

Contact Information

honglin@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2011.09 - 2015.06: PhD in Pathology and Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology Bachelor of Science in Biopharmaceuticals, Henan University of Technology (2007.09 - 2011.06) Presided over one National Natural Science Foundation of China, one Natural Science Foundation of Hubei Province, and one Fundamental Research Funds for the Central Universities
Work Experience	2022/12 - Present: Associate Professor, Associate Chief Technician, Department of Pathology, Renmin Hospital, Wuhan University 2017/12 - Present: Associate Chief Technician, Department of Pathology, Renmin Hospital, Wuhan University 2015/12 - 2017/11: Supervisor Technician, Department of Pathology, Renmin Hospital, Wuhan University 2015/07 - 2015/11: Technician, Department of Pathology, Renmin Hospital, Wuhan University
Awards	2022: Third Prize, Hubei Provincial Higher Education Teaching Achievement Award 2021: Third Prize, Hubei Provincial Science and Technology Progress Award 2021: Second Prize, Wuhan University Teaching Achievement Award

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2011.09 - 2015.06: PhD in Pathology and Pathophysiology, Tongji Medical College, Huazhong University of Science and Technology
Bachelor of Science in Biopharmaceuticals, Henan University of Technology (2007.09 - 2011.06)
Presided over one National Natural Science Foundation of China, one Natural Science Foundation of Hubei Province, and one Fundamental Research Funds for the Central Universities

Work Experience

2022/12 - Present: Associate Professor, Associate Chief Technician, Department of Pathology, Renmin Hospital, Wuhan University
2017/12 - Present: Associate Chief Technician, Department of Pathology, Renmin Hospital, Wuhan University
2015/12 - 2017/11: Supervisor Technician, Department of Pathology, Renmin Hospital, Wuhan University
2015/07 - 2015/11: Technician, Department of Pathology, Renmin Hospital, Wuhan University

Awards

2022: Third Prize, Hubei Provincial Higher Education Teaching Achievement Award
2021: Third Prize, Hubei Provincial Science and Technology Progress Award
2021: Second Prize, Wuhan University Teaching Achievement Award

Areas of Focus	Breast cancer tumor microenvironment Predictive markers of neoadjuvant chemotherapy efficacy Pathogenesis of nervous system diseases
Publications	Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway, Honglin Yan, Jie Rao, Jingping Yuan, Likun Gao, Wenxian Huang, Lina Zhao, Jiacai Ren, 2017 Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke, Xiaoxi Wang, Lei Pei, Honglin Yan, Zhongping Wang, Na Wei, Shan Wang, Xin Yang, Qing Tian, Youming Lu, 2014 Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer, Honglin Yan, Bin Luo, Xiaoyan Wu, Feng Guan, Xinxin Yu, Lina Zhao, Xiaokang Ke, Juan Wu, Jingping Yuan, 2021 Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients, Jingping Yuan, Huihua He, Chuang Chen, Juan Wu, Jie Rao, Honglin Yan, 2019 miR-21 regulates ischemic neuronal injury via the p53/Bcl-2/Bax signaling pathway, Honglin Yan, Wenxian Huang, Jie Rao, Jingping Yuan, 2021

Areas of Focus

Breast cancer tumor microenvironment
Predictive markers of neoadjuvant chemotherapy efficacy
Pathogenesis of nervous system diseases

Publications

Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate ischemic neuronal death by targeting miR-21/PDCD4 signaling pathway, Honglin Yan, Jie Rao, Jingping Yuan, Likun Gao, Wenxian Huang, Lina Zhao, Jiacai Ren, 2017
Intervention of death-associated protein kinase 1-p53 interaction exerts the therapeutic effects against stroke, Xiaoxi Wang, Lei Pei, Honglin Yan, Zhongping Wang, Na Wei, Shan Wang, Xin Yang, Qing Tian, Youming Lu, 2014
Cisplatin Induces Pyroptosis via Activation of MEG3/NLRP3/caspase-1/GSDMD Pathway in Triple-Negative Breast Cancer, Honglin Yan, Bin Luo, Xiaoyan Wu, Feng Guan, Xinxin Yu, Lina Zhao, Xiaokang Ke, Juan Wu, Jingping Yuan, 2021
Combined high expression of CD47 and CD68 is a novel prognostic factor for breast cancer patients, Jingping Yuan, Huihua He, Chuang Chen, Juan Wu, Jie Rao, Honglin Yan, 2019
miR-21 regulates ischemic neuronal injury via the p53/Bcl-2/Bax signaling pathway, Honglin Yan, Wenxian Huang, Jie Rao, Jingping Yuan, 2021

Breast Cancer Tumor Microenvironment Neoadjuvant Chemotherapy Efficacy Markers Nervous System Disease Pathogenesis Predictive Markers Cancer Research Clinical Pathology Molecular Diagnostics

Xu Binghe - Wuhan University

Xu Liying - Wuhan University

Shengrong Sun - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us